LiverMultiScan Publications

Clinical utility of MRI biomarkers for identifying NASH patients at high risk of progression: A multi-center pooled data and meta-analysis

Author: Andersson, A., Kelly, M., Imajo, K., Nakajima, A., Fallowfield, J. A., Hirschfield, G., Pavlides, M., Sanyal, A. J., Noureddin, M., Banerjee, R., Dennis, A., Harrison, S. 

Journal: Clinical Gastroenterology and Hepatology

Publication Year: 2021

Volume/Issue: S1542-3565(21)01056-9

Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway

Author: McKay, A., Pantoja, C., Hall, R., M

Journal: Journal of Patient-Reported Outcomes

Publication Year: 2021

Volume/Issue: 5(1)

Pages: 89

Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease

Author: Harrison, S. A., Baum, S. J., Gunn, N. T., Younes, Z. H., Kohli, A., Patil, R., Koziel, M. J., Chera, H., Zhao, J., Chakravarthy, M. V.

Journal: The American Journal of Gastroenterology

Publication Year: 2021

Volume/Issue: 10.14309/ajg.0000000000001375

Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease

Author: Janowski, K., Shumbayawonda, E., Cheng, L., Langford, C., Dennis, A., Kelly, M., Pronicki, M., Grajkowska, W., Wozniak, M., Pawliszak, P., Chełstowska, S., Jurkiewicz, E., Banerjee, R., Socha, P.

Journal: Scientific Reports

Publication Year: 2021

Volume/Issue: 11(1)

Pages: 15261